Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2025-06-20 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（刘万丽）
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes qualifications, compliance with regulatory requirements, and personal commitments related to the role of an independent director. There is no financial data, no report of financial results, no voting results, no meeting materials, and no announcement of a report publication. The content is focused on board/management information, specifically about a candidate for the board of directors. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short (3111 characters), and it is not an announcement or certification but a substantive statement related to board membership.
2025-06-20 Chinese
董事、高级管理人员任职薪酬、津贴管理制度
Remuneration Information Classification · 95% confidence The document is titled as a management system for the remuneration and allowances of directors and senior management personnel of the company. It details the salary structure, allowances, conditions for payment, and adjustments related to the compensation of board members and senior executives. There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, and no regulatory certifications. The content is focused on governance and internal rules regarding compensation. This fits the definition of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2025-06-20 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Board of Directors" of a company. It details the structure, responsibilities, rights, and operational procedures of the board of directors, including chapters on general provisions, directors, the board itself, the chairman, meeting convocations, meeting procedures, meeting records, and supplementary provisions. There is no financial data, earnings information, voting results, or announcements of reports. Instead, it is a governance document outlining internal rules and governance practices of the company. Therefore, this document fits the category of Governance Information (CGR).
2025-06-20 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '对外担保管理制度' (External Guarantee Management System) of 华兰生物工程股份有限公司. It outlines the company's rules, principles, approval procedures, risk management, and responsibilities related to providing external guarantees. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. It is a governance-related document detailing internal control and management practices for external guarantees, which aligns with governance information. It is not a report publication announcement or a certification. Therefore, the document best fits the category of Governance Information (CGR).
2025-06-20 Chinese
投资理财管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled 'Investment and Financial Management System' for a company, outlining procedures, responsibilities, and controls related to short-term financial investments. It does not contain financial statements, earnings data, or regulatory announcements. It is a governance-related document describing internal rules and management practices for investment activities. Therefore, it fits best under Governance Information (CGR). The document length is 2334 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification.
2025-06-20 Chinese
股东会议事规则
Governance Information Classification · 100% confidence The document is titled as "股东会议事规则" which translates to "Rules of Procedure for Shareholders' Meetings" for 华兰生物工程股份有限公司. It details the rules, procedures, and governance related to the conduct of shareholders' meetings, including the convening, proposal submission, voting procedures, and legal compliance. It does not contain financial statements, audit opinions, or earnings data. It is a governance document outlining internal rules and procedures for shareholder meetings, which fits the definition of Governance Information (CGR). The document length is substantial and it is not an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the appropriate classification is Governance Information (CGR).
2025-06-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.